WHAT: Hearing titled “Assessing America’s Vaccine Safety Systems, Part One” DATE: Thursday, February 15, 2023 TIME: 10:00 AM ET LOCATION: 2154 Rayburn House Office Building Wenstrup Announces Hearing on Vaccine Safety Reporting and Injury Compensation Systems Press Release WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) will hold a hearing titled “Assessing America’s Vaccine Safety Systems, Part One” […]
NAATs Used in Pfizer Clinical Trial to Test Asymptomatic Patients Despite Not Being Approved (or Even Emergency Use Authorized) for Asymptomatic Testing.
Nasal swab nucleic acid amplification tests (NAATs) are “a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19.” [https://www.cdc.gov/coronavirus/2019-ncov/lab/naats.html and https://www.fda.gov/consumers/consumer-updates/covid-19-test-basics] Although certain NAAT tests have now been authorized for emergency use (EUA) for screening purposes (in asymptomatic persons), the three NAAT tests used at the time […]
FDA and Pfizer Data Allegedly Missing IMPORTANT Blood Brain Barrier Data – Letter
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) Food and Drug Administration Dept. of Health and Human Services (HHS) Peter.Marks@fda.hhs.gov April 16, 2022 Dear Dr. Marks, I’ve just read an article stating highly inflammatory lipid nanoparticles (LNP)s “could be responsible for adjuvanticity and some […]